Turkish Journal of Medical Sciences
Volume 28

Number 2

Article 5

1-1-1998

Effects of Acute Hypothyroidism on BrainstemAuditory Evoked
Potentials (BAEPs)
Metin ÖZATA
Abdullah ÖZKARDEŞ
M. Ali GÜNDOĞAN

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
ÖZATA, Metin; ÖZKARDEŞ, Abdullah; and GÜNDOĞAN, M. Ali (1998) "Effects of Acute Hypothyroidism on
BrainstemAuditory Evoked Potentials (BAEPs)," Turkish Journal of Medical Sciences: Vol. 28: No. 2, Article
5. Available at: https://journals.tubitak.gov.tr/medical/vol28/iss2/5

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Tr. J. of Medical Sciences
28 (1998) 133-137
© TÜBİTAK

M. ÖZATA, et al.

Metin ÖZATA1
Abdullah ÖZKARDEŞ2
M. Ali GÜNDOĞAN1

Effects of Acute Hypothyroidism on Brainstem
Auditory Evoked Potentials (BAEPs)

Received: June 17, 1996

Abstract: Although functional alterations in
the central nervous system (CNS) and peripheral nerves are well documented in overt
hypothyroidism, little is known about alterations of CNS in acute hypothyroidism. Sixteen
patients with differentiated thyroid carcinoma
were studied when prepared for radioiodine
scanning after stopping levothyroxine (LT4)
therapy for 6 weeks to determine whether
acute hypothyroidism leads to alteration in
brainstem
auditory
evoked
potentials
(BAEPs). Repeat BAEPs were performed on
the same patients at 6 months of the following L-T4 therapy when patients were euthyroid. Neurophysiological findings were
compared with a group of 20 normal controls
with no hystory of thyroid disease. Wave I latency and I-III, III-V and I-V interpeak la-
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tencies in BAEPs were studied. A signifiant
prolongation of wave I latency found in patients with acute hypothyroidism when compared to those in control subjects. Abnormal
latencies were not correlated with thyroid
hormone levels. These neurophysiologic abnormalities were completely restored to normal at 6 months after L-T4 therapy. We conclude that acute hypothyroidism leads to
reversible alterations in peripheral components of BAEPs. Our results also suggest
that BAEPs could be useful tests to monitor
functionale alteration of the central nervous
system in acute hypothyroidism.
Key Words: Acute Hypothyroidism, BAEPs

Introduction

Materials and Methods

Thyroid hormone deficiency is associated with peripheral and central nervous system (CNS) dysfunctions
(1-9). CNS manifestations include somnolence, lethargy, mental retardation, memory changes, depression,
and rarely convulsions and coma (10). The CNS involvement in overt hypothyroidism has previously been
shown on the basis of visual evoked potentials in adult
patients (11-13) and of BAEPs and SSEPs in infants
(14-16). However, little is known about quantitive
changes in CNS after withdrawal of T4 in patients
with thyroid cancer. We previously shown that subclinical hypothyroidism does not lead to alteration in
BAEPs (17). However, no study reported the effects
of acute hypothyroidism on BAEPs sofar.

BAEPs recordings were performed in 16 patients
(6 male, 10 female; mean age 35.37±3.20 years)
with thyroid carcinoma (10 had papillary and 6 had
follicular cancer) when prepared for radioiodine scanning after stopping levothyroxine (L-T4) therapy for 6
weeks. All patients were clinically and biochemically hypothyroid 6 weeks after withdrawal of L-T4. The neurological examination was negative and all had a normal audiogram. Repeat BAEPs were recorded on the
same patients at 6 months of the following LT4 therapy when the patients were euthyroid. Neurophysiological findings before and after treatment were
compared with a group of 20 normal controls with no
history of thyroid disease (8 men, 12 female; age
32.25±3.07 years).

The aims of the current study therefore were:
to evaluate the alterations of CNS in acute hypothyroidism by recording BAEPs and to examine the
reversibility of the alteration, if any, with L-T4 treatment when patients were euthyroid.

All subjects had given their informed consent for
the present study. A history was taken and a complete
medical examination including neurological examination
was carried out for every patient. All patients and
controls had a full medical and laboratory evaluation
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(haematology, blood chemistry, urinalysisi) for exclusion of nonthyroidal illness. Serum levels of TSH, free
thyroid hormones (fT3, fT4), and thyroid autoantibodies were measured in all patients and controls
at the time of neurophysiological studies to assess the
thyroid status.
None of the patients had a nonthyroidal illness,
were taking medications or were pregnant. Also, none
of the patients had other concurrent disorders or factors causing polyneuropathy or degenerative CNS disease such as diabetes mellitus, uraemia, collagen disease, cancer chemotherapy and anti-convulsant
treatment. The patients or control subjects did not
have a history of central nervous system disorder such
as head injuri, congenital structural lesions, neurosurgical operations alcohol or drug abuse, and psychiatric illness.

olett Biomedical Instrument, Madison, WI, USA). Each
potential was obtained from the average of 2000 responses for a 10 msec period.
The components studied were the latencies of
peak I, and the interpeak intervals I-III, III-V and I-V
for both ears.
All results are given as means±SD. The mean values for each electrophysiological parameter in patients
with acute hypothyroidism and controls were compared using unpaired Student’s t-test. BAEPs values
before and at 6 months of the following LT4 treatment were compared using paired Student’s t-test.
Correlation coefficients between hormone values and
electrophysiological findings were calculated by Pearson’s correlation test. A, P<0.05 was considered statistically significant.

Hormone measurement
Free T3 (normal range: 2.2-4.7 pg/ml) and free T4
(normal range: 0.85-2.67 ng/dL) were measured by
radioimmunoassay (RIA) with reagents from Kodak
Clinical Diagnostics Ltd. Amersham (Burcks, UK) (Kodak Amerlex-Mab fT3 kit and Kodak Amerlex-Mab fT4
kit, respectiavely). We determined serum TSH (upper
limit of the normal reference interval was 6.5 mIU/
mL) by an immunoradiometric assay (IRMA) from
Medgenix Diagnostics SA (Fleurus, Belgium; TSH IRMA
kit, coated-tube).
BAEPs recording
BAEPs recording was performed using surface EEG
cup electrodes (silver chlodide electrodes, 10 mm cup,
Nicolet Biomedical Instrument, Madison, WI, USA) and
EEG paste (Ten 20 conductive EEG pate, Nicolett Biomedical Instrument, Madison WI, USA). BAEPs recording were carried out using Nicolett Compact Four
electrodiagnostic system (Nicolett Biomedical Instrument, Madison, WI, USA). Impedance remained under 5kΩ at all times during sessions.
The EP signals were obtained simultaneously, ipsilaterally and contralaterally, by using reference electrodes located on both mastoids and an active electrode at the vertex. We report only ipsilateral records
in this study. The ground electrode was placed on the
forehead. Potentials were evoked by monaural auditory stimuli consisting of cliks of alternate polarity
with a duration of 100msec, an intensity of 60 dB
SPL higher than hearing threshold, and a stimulation
frequency of 10 Hz via unshielded headphones (Nic-
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Results
Mean serum fT3, fT4 and basal TSH concentrations
for patients after stopping L-T4 therapy for 6 weeks
and control subjects are shown in Table 1. Serum free
thyroid hormone levels were found to be decreased
and patients were characterised by increased basal
TSH values after stopping L-T4 therapy. All patients
were clinically and biochemically hypothyroid. At 6
months of the following L-T4 therapy all patients are
clinically euthyroid and fT3, fT4 and TSH levels were
normal when repeated BAEPs were recorded.

Table 1.

Serum levels of fT3, fT4 and TSH in patients after stopping
LT4 therapy for 6 weeks and in controls subjects
fT3

fT4

Basal TSH

(pg/mL)

(ng/dL)

(µIU/mL)

Patients

1.36±0.24*

0.31±0.13*

66.76±8.21*

Controls

3.45±0.69*

1.75±1.58*

3.51±1.42*

Values given are means ±SD,
* p<0.001 vs patient and control groups.
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Table 2.

Electrophysiological findings in patients with
hypothyroidism before treatment and the controls

Patients

Controls

(n:16)

(n:20)

acute

Table 3.

Electrophysiological findings in patients after stopping LT4
therapy and at 6 months after commencement of LT4
therapy

P
Before treatment

After treatment

P

I.Wave (msec)

1.72±0.25

1.54±0.09

0.029

I-III IPL (msec)

2.18±0.30

2.06±0.26

NS

III-V IPL (msec)

1.92±0.20

1.91±0.15

NS

I-V IPL (msec)

4.11±0.20

3.99±0.28

NS

I.Wave (msec)

1.78±0.30

1.57±0.12

0.015

I-III IPL (msec)

2.19±0.22

2.11±0.20

NS

III-V IPL (msec)

1.99±0.51

1.92±0.16

NS

I-V IPL (msec)

4.18±0.45

4.03±0.29

NS

BAEPs
BAEPs
Right
Right
I.Wave (msec)

1.72±0.25

1.55±0.10

0.023

I-III IPL (msec)

2.18±0.30

2.07±0.23

NS

III-V IPL (msec)

1.92±0.20

1.91±0.13

NS

I-V IPL (msec)

4.11±0.20

3.99±0.26

NS
Left

Left
I.Wave (msec)

1.78±0.30

1.58±0.12

0.022

I-III IPL (msec)

2.19±0.22

2.13±0.18

NS

III-V IPL (msec)

1.99±0.51

1.92±0.16

NS

I-V IPL (msec)

4.21±0.47

4.06±0.27

NS

Values given are means± SD
Values given are means ± SD

BAEPs recordings in a patient with acute hypothyroidism before therapy are shown in Figure 1.

NS: not significant

There was no correlation between hormone levels
and electrophysiological parameters.

The electrophysiologic parameters in patients after
stopping therapy and controls are shown in Table 2.
A significant prolongation of wave I lacenty in BAEPs
was found in patients with acute hypothyroidism
when compared to those in control group. However,
interpeak latencies in BAEPs did not yiield statistically
significant differences between patient and control
groups. L-T4 therapy significantly reduced the mean
right and left wave I latencies of BAEPs (1.72±0.25
to 1.54±0.09 msec, P=0.029 and 1.78±0.30 to
1.57±0.12 msec, P=0.015, recpectively) (Table 3).

Discussion
It is well known that overt hypothyroidism is associated with mononeuropathy or sensorimotor polyneuropathy due to primarily axonal damage or involvement of myelin (1-6). The electrophysiologic
abnormalities such as slowing of motor and sensory
nerve conduction velocities have been shown in overt
Figure 1.
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hypothyroidism (1-6). It is also known that thyroid
hormones interfere with many of the processes in the
nervous system (10). The CNS involvement in overt
hypothyroidism has previously been shown on the basis of visual evoked potentials in adult patients (1113) and of BAEPs and SSEPs in infants (14-16).
However, little is known about quantitative changes in
CNS after withdrawal of T4 in patients with thyroid
cancer. Furthermore, no study reported the effects of
acute hypothyroidism on BAEPs in adult patients to
date. We therefore recorded BAEPs to assess the alteratinos of central nervous system in adult patients
with acute hypothyroidism.
Brainstem auditory evoked potentials (BAEPs)
have come into widespread use for assesment of the
clinical state of the middle portion of the brainstem
(18). BAEPs allow evaluation of the functional integrity of the auditory pathways, from the auditory
nerve to the thalamic nuclei (18,19). Using this technique, we recorded BAEPs in our patients with acute
hypothyroidism. A significantly increased wave I latencies was found, whereas interpeak latencies were
normal. Our results show that acute hypothyroidism
leads to peripheral deficit in BAEPs since wave I generated primarily by the VIIth nerve. Similarly, Laureau
et al. (16,20) reported that congenital hypothyroidism
causes the peripheral abnormalities in BAEPs. Increased wave I lacenty is indicative of delayed peripheral transmission. Since our patients had normal
audiogram, finding of a delayed wave I latency is due
to acute hypothyroidism but not inner ear or coclear
abnormalities. Reversibilty of abnormal wave I latency
after restoration of euthyroidism also support that the
T4 deficiency is responsible for the wave I abnormalities in BAEPs. However, it is not clear why impairment of interpeak latencies were not observed in
acute hypothyroidism. It is possible that peripheral
components of BAEPs are more sensitive to thyroid
hormone deficiency.
Low body temperature, diminished myelin production and alteration in cerebral metabolism during
acute hypothyroidism may be the possible explanations
for the prolongation of wave I latency. The influence
of low temperature in acute hypothyroidism could be

considered because hypothermia in adult patients with
overt hypothroidism causes an additional slowing of
both peripheral and central conduction (21). Thyroid
hormone is known to influence the synthesis of proteins and production of enzymes and myelin (10).
Thus acute hypothyroidism may cause the diminished
myelin synthesis (22). A recent study (23), using P-31
nuclear magnetic resonance (NMR) spectroscopy, also
demonstrated that acute hypothyroidism in patients
with thyroid cancer after withdrawal of L-T4 leads to
reversible alterations in adult cerebral phosphate metabolism.
We did not find any correlations between serum
fT4 and BAEPs parameters. The several factors, such
as a nonlinear relation between serum T4 and the
5’deiodinase activity, the interference of the T4 bloodbrain barrier and time lag between T4 and BAEPs alterations, may disturb direct relation.
Initial abnormal components of BAEPs in patients
with acute hypothyroidism were completely restored to
normal at 6 months of the following LT4 therapy.
Thus, the present study indicates that acute hypothyroidism leads to reversible abnormalities of peripheral components of BAEPs. These results also reflect an effect of acute thyroid hormone deficiency on
the CNS. Reversible alteration of the CNS functions
has previously been shown by using visual evoked responses in patients with overt hypothyroidism (11-13).
However, we have the first to show reversible alteartions of CNS in adult patients with acute hypothyroidism by using BAEPs.
We conclude that acute hypothyroidism leads to
reversible alterations in central nervous system as determined by BAEPs recordings. Our results also suggest that BAEPs could be useful tests to monitor functional alteration of the central nervous system in acute
hypothyroidism.
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